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Abstract
The prevalent de novo biosynthetic pathway of vitamin B6 involves only two enzymes (Pdx1 and Pdx2) that form an ornate
multisubunit complex functioning as a glutamine amidotransferase. The synthase subunit, Pdx1, utilizes ribose 5-phosphate
and glyceraldehyde 3-phosphate, as well as ammonia derived from the glutaminase activity of Pdx2 to directly form the
cofactor vitamer, pyridoxal 59-phosphate. Given the fact that a single enzyme performs the majority of the chemistry behind
this reaction, a complicated mechanism is anticipated. Recently, the individual steps along the reaction co-ordinate are
beginning to be unraveled. In particular, the binding of the pentose substrate and the first steps of the reaction have been
elucidated but it is not known if the latter part of the chemistry, involving the triose sugar, takes place in the same or a
disparate site. Here, we demonstrate through the use of enzyme assays, enzyme kinetics, and mutagenesis studies that
indeed a second site is involved in binding the triose sugar and moreover, is the location of the final vitamin product,
pyridoxal 59-phosphate. Furthermore, we show that product release is triggered by the presence of a PLP-dependent
enzyme. Finally, we provide evidence that a single arginine residue of the C terminus of Pdx1 is responsible for coordinating
co-operativity in this elaborate protein machinery.
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Introduction
Vitamin B6 is essential for all organisms and has been shown to
be involved in a diverse array of processes from the maintenance
of the nervous and immune systems in animals and humans [1], to
playing a role as an antioxidant in several different organisms [2–
4] and more recently to potentially act as an antitumor agent [5].
It is a necessary cofactor in its form as pyridoxal 59-phosphate
(PLP), being required for the catalytic activity of over 140
metabolic enzymes. As a cofactor, it has been described as
participating in transamination, decarboxylation, racemization,
a,b-elimination and Ca-Cb bond cleavage reactions [6]. Two
routes to de novo vitamin B6 biosynthesis have been described,
according to the enzymes and substrates used [7]. The less
common route found in Escherichia coli and a few other members of
the c-division of proteobacteria that involves seven enzymes, is
referred to as the DXP-dependent pathway [8], since it utilizes
deoxyxylulose 5-phosphate (DXP) as a precursor to form the
vitamin [9–11]. However, most organisms that can synthesize this
vitamin, including fungi, plants, the majority of eubacteria and
archaea, utilize a DXP-independent pathway, which remarkably
involves only two enzymes, Pdx1 and Pdx2 [3,12–14]. The latter
two entities function as a glutamine amidotransferase that utilizes
ribose 5-phosphate (R5P) and glyceraldehyde 3-phosphate (G3P)
as well as glutamine to directly synthesize PLP [15,16]. The
complex of Pdx1 and Pdx2 displays a surprisingly ornate
architecture, which in bacteria consists of 24 subunits; two
hexameric rings of the synthase, Pdx1 (a (b/a)8-barrel), to which
the glutaminase, Pdx2 (a three-layered aba sandwich), attaches to
each individual Pdx1 subunit [17,18]. Pdx1 active site residues
have been confirmed to be located at the C-terminal end of its (b/
a)8-barrel, whereas the active site of Pdx2 is located at its interface
with the N-terminal region of Pdx1 at the other end of the (b/a)8-
barrel [17,18]. The ammonia resulting from glutamine hydrolysis
by Pdx2 is thought to be channeled in a putative tunnel to Pdx1
during the initial steps of pyridoxal 59-phosphate formation [17].
While a comparison by X-ray crystallography of the Pdx1
oligomer with the Pdx1-Pdx2 complex as well as biochemical
analyses revealed regions that become ordered upon complex
formation [17–21], namely an extra N-terminal a-helix, aN, as
well as an extra internal a-helix, a29, the C terminus of Pdx1
consisting of 24 amino acids in Bacillus subtilis had eluded structural
characterization, due to its inherent flexibility. Recently, it was
shown to be required for catalysis, indeed mediating intersubunit
cross-talk between two neighboring protomers of Pdx1, in addition
to acting as a flexible lid that bridges and shields the active site of
an adjacent subunit [21]. Moreover, the latter study showed that
R5P triggers co-operativity within Pdx1, a feature coordinated by
the C terminus, and furthermore that the affinity for the substrate
is enhanced upon interaction with the Michaelis complex of Pdx2
and glutamine suggesting allostery. However, the key residue(s)
involved in these molecular gymnastics remained to be elucidated.
As for other (b/a)8-barrel proteins, the active site located at the
C-terminal end of the barrel in Pdx1 was implicit and has been
shown by mass spectrometry and X-ray crystallography to
accommodate the pentose phosphate substrate, R5P, and is
referred to as P1 (for phosphate binding) [17–19,22]. However, the
accommodation of the second substrate, G3P, in addition to how
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could not be accounted for. Interestingly, in the several structures
of bacterial Pdx1’s that have been determined so far, sulfate,
chloride or phosphate ions were shown to bind to a second site,
referred to as P2, located at the hexamer interface of the Pdx1
dodecamer [17–20]. The P2 site is made up from H115, R137,
R138 in addition to K187 from a69 of a subunit of the opposing
hexamer (B. subtilis numbering). To date, this site has not been
probed for functionality during the course of PLP biosynthesis.
Intriguingly, while the isolated intermediates along the first-half of
the reaction co-ordinate with the pentose phosphate substrate have
been shown to be covalently attached to K81 in the P1 site, a
second conserved lysine residue (K149), located between the P1
and P2 sites, albeit pointing towards the latter, has been
demonstrated to be involved in PLP formation [16,22,23].
However, its molecular role has not been defined. Thus, given
the above facts, there is precedence for a catalytic function within
the P2 site.
Here, firstly, we dissect the functionality of the flexible C
terminus of Pdx1 and show that a single arginine residue is
fundamental for coordinating active site closure and co-operativity
within Pdx1 itself, upon binding the pentose phosphate substrate.
Moreover, the role of this residue, acts independently to the
allostery imparted by Pdx2, which enhances the affinity for the
substrate. Furthermore, we show that the P2 site is necessary for
the transformation of the second substrate, G3P, into the product
and is also where the completion of the synthesis of the PLP
molecule takes place. Finally, we demonstrate that the PLP
product remains covalently bound to K149, ratifying the role of
this residue, and that release of the product is triggered by the
presence of an enzyme dependent on PLP as a cofactor. The latter
serves to regulate the release of the PLP molecule such that the
expected non-specific chemical reactivity of this aldehyde can be
controlled to prevent damage within the cellular milieu.
Results
A C-terminal arginine residue is essential for
co-operativity observed in PLP synthase
Given the recent demonstration that the flexible C-terminal
region of Pdx1 is essential for catalysis [21], we sought to identify
the key residue(s) in this region necessary for maintaining
functionality. Of the residues in this part of the Pdx1 protein,
we noted the strict conservation of an arginine residue (R288 B.
subtilis numbering) at the very C terminus [21]. Site directed
mutagenesis was utilized to probe its functionality by mutation to
either an alanine or a lysine (R288A or R288K, respectively).
Enzymatic activity was monitored in either of the three ways
possible for PLP synthase, i.e. the ability to form the chromophoric
intermediate along the reaction co-ordinate [22], the product PLP,
or the capacity of Pdx1 to initiate glutaminase activity in its
partner protein Pdx2 [15]. Both the Pdx1 R288A and R288K
muteins were able to activate the glutaminase activity of Pdx2 to a
similar extent as the wild type protein (Figure 1A and Table 1A).
This indicates that such a mutation in the C-terminal region of
Pdx1 does not affect the 3D fold of this enzyme, at least at the
Pdx1-Pdx2 interface. However, the specificity constant for the
formation of the chromophoric intermediate with Pdx1 R288A
was estimated to be reduced 9-fold compared to wild type (kcat/
KM 0.09 min
21.M
21 and 0.8 min
21.M
21, respectively) as reflect-
ed in both kcat and KM, whereas no significant change in the
activity of the R288K mutein compared to wild type was noted
(Figure 1B and Table 1A). Furthermore, while the kcat for PLP
formation by either mutant enzyme was not significantly affected
compared to wild type enzyme, it could be seen that there was a
significant increase in the KM for R5P with the R288A mutein,
while no significant change was observed for G3P (Figure 1C and
D and Table 1A). Therefore, we postulated that R288 is, at least,
necessary for the efficiency of Pdx1 with the R5P substrate and
may be directly involved in its binding.
In this context, we recently demonstrated binding of R5P to
Pdx1 by fluorescence spectroscopy through the fortuitous presence
of a single tryptophan residue at the very C terminus of the B.
subtilis protein. Specifically, in the presence of the pentose
phosphate substrate, there is an increase in the fluorescence
emission maximum of Pdx1 at 350 nm [21]. Moreover, changes
in the intrinsic protein fluorescence as a function of the pentose
phosphate sugar concentration demonstrated co-operativity in
Pdx1 upon binding this substrate, with a corresponding Hill
coefficient of approximately 3.3 [21]. Here a comparison of the
wild type enzyme with the two R288 muteins shows that co-
operativity is completely abolished with the R288A mutant
protein, whereas co-operativity is still observed with the lysine
mutant (Figure 1E). However, while the Hill coefficient observed
with Pdx1 R288K is similar to that of the wild type enzyme
(3.260.3) there is a significant increase in K0.5 (348613 mM)
compared to the wild type enzyme (18362 mM). As one of the first
steps in PLP synthase catalysis is the covalent binding of the
pentose phosphate sugar substrate to an active site lysine residue,
manifested as an additional mass of 212 Da [16,18,22], we also
made use of ESI-MS to establish if R5P indeed binds to the Pdx1
muteins. This analysis revealed that both Pdx1 mutants can form
the R5P covalent adduct as for wild type under the same
conditions (Figure 1F). Therefore, we can infer that R288 is
necessary to communicate the cooperative response to the
neighboring protomer to enhance the efficiency of transformation
of the R5P substrate.
Furthermore, the Michaelis complex of Pdx2 and glutamine has
an allosteric effect on Pdx1, observed as a decrease in K0.5 for R5P
upon formation of the Pdx1:R5P:Pdx2:glutamine quaternary
complex [21]. This can be demonstrated by incubating Pdx1
with the catalytically inert Pdx2 H170N mutein and glutamine all
of which are known to assemble as a stable 1:1 protein complex
referred to as preassembled PLP synthase [17], and titrating with
R5P. Here we assessed the effect of the R288A and R288K
muteins on the allostery observed in Pdx1. As shown in Figure 1G,
a significant reduction in K0.5 for R5P was observed with wild type
Pdx1 in complex with Pdx2 H170N:glutamine compared to Pdx1
alone (62.462 mM and 18362 mM, respectively) with a slightly
reduced Hill coefficient for the preassembled PLP synthase
complex (2.660.2) corroborating our earlier results [21]. Interest-
ingly, in the presence of Pdx2 H170N and glutamine, the Pdx1
R288A mutein regains the ability to bind the pentose phosphate
substrate in a co-operative manner. However, both the Hill
coefficient (1.960.2) and K0.5 (114610.8 mM) were impaired in
comparison to the wild type enzyme. The behavior of the R288K
mutant was also affected compared to the wild type enzyme
(2.260.3 and 91.267 mM for the Hill coefficient and K0.5,
respectively) but to a lesser extent than Pdx1 R288A (Figure 1G).
The fluorescence spectroscopy approach can also be used to probe
conformational changes upon interaction of Pdx1 with just the
Michaelis complex of Pdx2 H170N and glutamine, i.e. in the
absence of R5P, as demonstrated by Raschle et al. [21].
Specifically, titration of Pdx1 with Pdx2 H170N in the presence
of glutamine leads to a decrease in fluorescence intensity as a
function of the concentration of Pdx2 H170N and glutamine,
demonstrating an allosteric effect of Pdx2:glutamine on the
spatially separated C-terminal region of Pdx1. The analogous
Insight into the Mechanism of PLP Synthase
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the wild type Pdx1 enzyme (Figure 1H). As an additional control
we also estimated the oligomeric state of the R288A mutein using
size exclusion chromatography coupled to static light scattering.
This experiment showed that Pdx1 R288A behaves similar to the
wild type enzyme, i.e. it retains the ability to form the dodecamer
(Figure S1A and B).
All of the above data demonstrates that the functionality of this
conserved arginine residue is exclusive to the presence of R5P. As
the C terminus is thought to bridge adjacent protomers and as we
observed an affect on both R5P binding as well as catalysis, we
tested the hypothesis that R288 could pose as an ‘‘arginine finger’’.
The latter is frequently observed in multimeric protein structures
and plays either a structural or catalytic role [24,25]. In its latter
capacity the arginine finger has been shown to trigger phosphate
hydrolysis in an adjacent protomer [26]. As one of the steps
preceding chromophoric adduct formation in the biosynthesis of
PLP is release of inorganic phosphate from R5P [22], we tested if
R288 is necessary for this step in PLP synthase. However, no
significant change was observed for either the R288A or R288K
muteins compared to wild type (Table S1 and Figure S2). Thus, it
must be inferred that R288 is mainly a structural determinant
essential for R5P binding and co-operativity in Pdx1.
Assigning functionality to the P2 site of Pdx1 in PLP
synthesis
Two phosphate binding sites (referred to as P1 and P2) have
been assigned to the synthase subunit, Pdx1, based on the co-
crystallization of either pent(ul)ose phosphate sugar substrate or
buffer inorganic anions, respectively, and as resolved in the X-ray
structures of the Pdx1 proteins from Geobacillus thermophilus, B.
subtilis, Thermotoga maritima and Saccharomyces cerevisiae [17–19]
(Figure 2A). The Pdx1 P1 site has been unequivocally demon-
strated to be the R(u)5P binding site [18] and the catalytic
functionality of many of the residues in this area have been
confirmed [17]. However, it is not known whether the entire
chemistry of PLP biosynthesis takes place at Pdx1 P1 or if indeed
the Pdx1 P2 site plays any role in this process. The most highly
conserved residues surrounding this potential phosphate binding
site are H115, R137, R138 in combination with K187 from a
neighboring Pdx1 protomer of the adjacent hexamer (Figure 2A,
B. subtilis numbering) [17]. In an attempt to assign functionality,
we performed site directed mutagenesis of each of these residues to
an alanine, in addition to constructing the double mutant H115A/
R138A. The R137A mutation led to a misfolded version of the
Pdx1 protein and was not pursued further (data not shown). The
three enzymatic assays described earlier were used to characterize
the remaining mutants with respect to their ability to form the
chromophoric intermediate, the product PLP and to activate
glutamine hydrolysis in Pdx2. All mutants were able to activate the
glutaminase activity of Pdx2 (Table 1B) and retained the ability to
form the R5P chromophoric intermediate with similar catalytic
parameters to wild type Pdx1 (Table 1B). It is noteworthy that the
C-terminally hexahistidine tagged versions of the Pdx1 wild type
and P2 muteins (Table 1B) have slightly impaired catalytic activity
for the formation of the chromophore compared to the native
enzymes used to probe functionality of R288 (Table 1A).
However, clear catalytic perturbations were observed for the
formation of the product PLP (Table 1B). PLP formation was
estimated to be 33%, 22% and 17% of the wild type activity for
R138A, H115A and the H115A/R138A double mutant, respec-
tively, while the activity of K187A was shown to be 84% of the
wild type activity. The dramatic reduction in catalytic rate of
R138A, H115A and the corresponding double mutant was mainly
manifested in the kcat, severely impairing substrate specificity and
demonstrating that these residues have a catalytic role to play in
PLP formation. Interestingly, mutations in the Pdx1 P2 site
consistently increased the KM for G3P (up to 2-fold), while no
corresponding effect was observed in the KM for R5P (Table 1B).
Moreover, ESI-MS as described above, confirmed that all muteins
could bind R5P (data not shown). Given the bias of the Pdx1 P2
muteins towards the later steps in PLP formation, i.e. post
chromophoric intermediate formation, and in particular the effect
on G3P binding, we decided to probe product formation further.
Two points are important to note in this context; firstly, the major
rate-limiting step along the PLP biosynthesis reaction co-ordinate
is in fact dissociation of the product [27] and secondly, the
maximum absorbance for the formation of the product is at
414 nm in different buffers examined (i.e. phosphate, HEPES) at
pH 8.0. This indicates that PLP is bound in a Schiff’s base to Pdx1
(similar to enzymes dependent on it as a cofactor [28]), as free
PLP, on the other hand, has an absorbance maximum at 388 nm
[29]. Indeed, when we treated Pdx1 de novo synthesized PLP with
0.1 M sodium hydroxide there was a hypsochromic shift in the
absorbance spectrum to a maximum at 388 nm (Figure 2B). This
behavior is typical for PLP bound in a Schiff’s base to a lysine
residue in a protein [29]. Additionally, ESI-mass spectrometry
analysis showed that wild type Pdx1 harboring PLP generated de
novo followed by reduction with sodium borohydride displays an
additional mass 231 Da above that of the observed mass of the
apoprotein (32834.8 Da), and corresponds to a PLP-conjugated
lysine (Figure 2C). Note, the additional peak observed at
32932.3 Da (+97 Da) in this spectrum is most likely due to the
presence of residual Pdx1 with the covalently bound chromo-
phoric intermediate in a reduced state [22]. These latter
observations demonstrate that PLP is covalently bound to Pdx1
and prompted us to investigate its location within the protein. To
identify the binding site of PLP, a single turnover of the
biosynthesis reaction was reconstituted by incubating the wild
type enzyme with the substrates, R5P and G3P while substituting
Pdx2 and glutamine for ammonium sulfate. As for many other
glutamine amidotransferases, an external source of ammonia (e.g.
ammonium sulfate) can substitute for that provided by glutamine
in the presence of the glutaminase domain [15]. As above, the final
reaction intermediate was trapped by reduction with sodium
borohydride and the resulting protein was subjected to digestion
with trypsin. A direct analysis of the resulting peptides by MALDI-
TOF mass spectrometry did not reveal any masses corresponding
Figure 1. Arginine 288 is essential to co-ordinate the positive co-operative effect of ribose 5-phosphate in Pdx1. (A–D), Glutaminase,
chromophore and PLP synthase activity as a function of glutamine (Gln), ribose 5-phospate (R5P) or glyceraldehyde 3-phosphate (G3P), respectively,
of Pdx1 wild type (#), Pdx1 R288A (N) or Pdx1 R288K (.). (E) Titration of either Pdx1 wild type (#), Pdx1 R288A (N) or Pdx1 R288K (.) with
increasing concentrations of R5P. A plot of the relative fluorescence change at 350 nm (excitation l=295 nm) versus the concentration of R5P
demonstrates sigmoidal binding behavior for wild type and R288K, but not for R288A. (F) ESI-mass spectra of Pdx1 wild type (1–2), Pdx1 R288A (3–4)
and Pdx1 R288K (5–6) in the absence (1,3,5) or presence (2,4,6) of R5P. The m/z difference of 212 Da in the presence of the substrate results from the
binding of R5P to form a covalent adduct with Pdx1 [22]. (G) Titration of either preassembled PLP synthase (i.e. Pdx1, Pdx2 H170N and glutamine,
[21]) with increasing concentrations of R5P. Preassembled PLP synthase exhibits sigmoidal binding behavior similar to that of Pdx1 alone but with a
reduced K0.5 for R5P. (H) Relative fluorescence change of Pdx1 in the presence of increasing concentrations of Pdx2 H170N and added glutamine.
doi:10.1371/journal.pone.0016042.g001
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shown). However, reduction of a Schiff’s base between PLP and a
residue within a peptide facilitates its isolation by RP-HPLC
coupled to a fluorescence detector, as such peptides have an
intrinsic fluorescence at 390 nm [30]. The elution profile of
sodium borohydride treated Pdx1 revealed the appearance of a
prominent new fluorescence peak in the reduced sample
(Figure 3A). Analysis by MALDI-TOF mass spectrometry
indicated the mass of an expected peptide within Pdx1, namely
TKGEPGTGNIVEAVR (expected mass 1527.8 Da) with a
Table 1. Kinetic constants for the three measurable catalytic activities of PLP synthase: Pdx1 chromophore activity, PLP synthesis
activity and Pdx2 glutaminase activity.
Table 1A: Summary of Pdx1 R288 mutein kinetic constants
a
KM R5P kcat kcat/KM
Chromophore activity (mM) (min
21)( m i n
21.mM
21)
Pdx1 wild type 0.2560.01 0.2060.01 0.80
R288K 0.2060.01 0.2260.01 1.10
R288A 0.8560.07 0.0860.00 0.09
KM R5P KM G3P kcat kcat/KM R5P kcat/KM G3P
PLP activity (mM) (mM) (min
21)( m i n
21.mM
21)( m i n
21.mM
21)
Pdx1 wild type 0.03260.008 0.18660.017 0.03360.002 1.031 0.177
R288K 0.04360.003 0.19560.033 0.03760.002 0.925 0.189
R288A 0.12260.006 0.22060.031 0.03060.002 0.245 0.136
KM glutamine kcat kcat/KM
Pdx2 glutaminase activity (mM) (min
21)( m i n
21.mM
21)
Pdx1 wild type 1.1660.18 1.7760.08 1.53
R288K 0.9360.15 1.8460.08 1.97
R288A 1.2060.08 1.8360.04 1.53
aAssays were performed at 37uC in 50 mM Tris-Cl, pH 7.5 employing native (untagged) proteins
Table 1B: Summary of Pdx1 P2 mutein kinetic constants
a
KM R5P kcat kcat/KM
Chromophore activity (mM) (min
21)( m i n
21.mM
21)
Pdx1 wild type 0.2060.01 0.04260.001 0.21
R138A 0.1760.01 0.05060.001 0.29
H115A 0.1960.03 0.03260.002 0.17
K187A 0.2060.02 0.03860.001 0.19
H115A/R138A 0.1660.02 0.03360.008 0.21
E105D 0.1660.02 0.07160.002 0.44
KM R5P KM G3P kcat kcat/KM R5P kcat/KM G3P
PLP activity (mM) (mM) (min
21)( m i n
21.mM
21)( m i n
21.mM
21)
Pdx1 wild type 0.04060.001 0.15560.023 0.03660.005 0.900 0.232
R138A 0.04460.005 0.26260.026 0.01260.001 0.273 0.046
H115A 0.03560.002 0.22960.055 0.00860.000 0.228 0.035
K187A 0.02660.005 0.26760.018 0.03060.001 1.153 0.112
H115A/R138A 0.04360.005 0.30760.075 0.00660.000 0.140 0.020
E105D 0.04060.005 0.24960.026 0.01460.001 0.350 0.056
KM glutamine kcat kcat/KM
Pdx2 glutaminase activity (mM) (min
21)( m i n
21.mM
21)
Pdx1 wild type 1.1660.16 1.4560.08 1.25
H115A 1.3360.18 1.3260.05 1.00
R138A 1.5460.19 1.4660.06 0.95
K187A 1.3160.15 1.4260.05 1.08
H115A/R138A 1.4460.15 1.4160.05 0.98
E105D 1.1260.14 1.5860.06 1.41
aAssays were performed at 37uC in 50 mM Tris-Cl, pH 7.5 employing hexahistidine tagged proteins
Pdx1 wild type and various muteins are as indicated. R5P and G3P refer to ribose 5-phosphate and glyceraldehyde 3-phosphate, respectively.
doi:10.1371/journal.pone.0016042.t001
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in addition to the precursor ion of m/z=1758.8 Da, we
predominantly observed bands at an m/z of 1660 and 1527.8,
corresponding to a loss of phosphoric acid (98 Da) and the
pyridoxal moiety (133 Da), respectively (Figure 3B). A MALDI-
TOF/TOF analysis of all three precursor ions yielded the
sequence TKGEPGTGNIVEAVR (Figure 3C). As there is only
a single lysine residue within this peptide, corresponding to K149,
this demonstrates that the final intermediate in the biosynthesis of
the PLP molecule must be in a Schiff’s base with K149 in Pdx1.
Given that covalent intermediates have been identified at K81 in
P1 [18,22] and now K149 in P2, it must be deduced that there is
transfer of an intermediate along the reaction co-ordinate from the
Pdx1 P1 to the Pdx1 P2 site. We noted the presence of a highly
conserved glutamate residue (E105) that is located between K81
and K149 (Figure 2A). Site directed mutagenesis was utilized to
probe changes in activity upon mutation to either an alanine or an
aspartate (E105A or E105D, respectively). However, as the
hydrolysis of glutamine is impaired for E105A, indicating a
change in folding of this mutant and even though the
chromophoric adduct can be formed but no PLP activity is
detected with this mutation (data not shown), we will refrain from
including this data in a functional hypothesis for this residue.
Nevertheless, the Pdx1 E105D mutein was able to activate
glutaminase activity to a similar extent as the wild type protein
(Table 1B). Interestingly, the specificity constant for the formation
of the chromophoric intermediate with Pdx1 E105D was
estimated to be increased 2-fold compared to wild type (kcat/KM
0.44 min
21.M
21 and 0.21 min
21.M
21, respectively). Indeed,
while the kcat for PLP formation of this mutant enzyme was
significantly decreased compared to wild type, it could be seen that
there was also a significant increase in the KM for G3P with the
E105D mutein, while no significant change was observed for R5P
(Table 1B). This data suggests that this residue may provide a
‘‘steric gate’’ in the transfer of an intermediate between the Pdx1
P1 and P2 sites.
Product release is triggered by an enzyme dependent on
it as a cofactor
We next attempted to explain the observation that the final
reaction product PLP is tightly bound to the enzyme [27,31] in a
more physiological context. As stated above, this represents a rate-
Figure 2. Substrate and product binding in Pdx1. (A) A single subunit of Pdx1 with ribulose 5-phosphate bound (Protein Data Bank code 2ISS).
The P1 and P2 phosphate-binding sites are indicated as orange and red spheres, respectively. Catalytic and/or binding residues in the P2 site are
highlighted. (B) Pdx1 covalently binds PLP. The dashed line represents Pdx1 wild type (100 mM) that had made PLP de novo. The solid line represents
the previous sample treated with 0.1 M sodium hydroxide. The dotted line represents 20 mM HEPES buffer alone at pH 8 containing 150 mM sodium
chloride. (C) ESI-MS analysis of Pdx1 wild type with reduced PLP. Reduction of the final product PLP on Pdx1 wild type reveals masses corresponding
to the unmodified protein (32834.8 Da) and that with PLP bound (33065.8 Da; +231 Da), in addition to that corresponding to the protein with
chromophoric intermediate covalently bound in the reduced form (32932.3 Da; +97 Da).
doi:10.1371/journal.pone.0016042.g002
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that the retention of the product by the enzyme serves to regulate
the release of the PLP molecule such that the expected non-
specific chemical reactivity of this aldehyde can be controlled to
prevent damage within the cellular milieu. In this context, release
of the PLP molecule would be anticipated in the presence of an
Figure 3. The final reaction steps of vitamin B6 biosynthesis take place at a second active site in Pdx1. (A) RP-HPLC elution profile of
tryptic peptides of Pdx1 based on the absorbance at 215 nm, following PLP reconstitution and reduction to trap the final product. The gray line
indicates the elution profile based on the fluorescence emission at 390 nm upon excitation at 320 nm. (B) MALDI-TOF/TOF analysis of the precursor
ion m/z=1758.8 [M+H]
+; a predominant loss of 98 Da corresponds to loss of phosphoric acid (m/z=1660.8 [M+H]
+), while a further loss of 133 Da
corresponds to loss of the pyridoxal moiety (m/z=1527.8 [M+H]
+) matching the unmodified peptide. (C) MALDI-TOF/TOF analysis of the precursor ion
m/z=1527.8 [M+H]
+, yielded a fragmentation pattern matching the predicted profile for the peptide TKGEPGTGNIVEAVR (residues 148–162).
Observed b (red) and c (blue) ions are indicated.
doi:10.1371/journal.pone.0016042.g003
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we cloned, expressed and purified a putative aspartate amino-
transferase from B. subtilis (annotated as AAT2) that would be
expected to use PLP as a cofactor. Activity measurements
confirmed that BsAAT2 catalyses the formation of L-glutamate
and oxaloacetate from L-aspartate and a-ketoglutarate in a PLP-
dependent manner (Figure 4 and Table 2). Notably, the activity of
BsAAT2 as isolated increased 5-fold in the presence of a
stoichiometric concentration of PLP generated de novo from a
single turnover reaction in Pdx1. This implies that the BsAAT2 as
isolated was not saturated with PLP. Importantly, the activity did
not increase in the presence of apoPdx1, Pdx1 where the PLP had
been irreversibly reduced with sodium borohydride, or Pdx2,
which does not contain PLP (Figure 4 and Table 2). These results
suggest that the PLP-dependent enzyme AAT2 from B. subtilis is
able to trigger hydrolysis and release of PLP from Pdx1, allowing
transfer of this highly reactive co-factor to the PLP-dependent
enzyme. Indeed, we could no longer detect the formation of PLP
by Pdx1 in the presence of AAT2 under these steady state
conditions, indicating that the transfer is immediate (data not
shown).
Discussion
The PLP synthase complex appears to be exceptional in its
intrinsic multiple catalytic abilities, ranging from its presumed
pentose and triose isomerizations to ammonia addition and
aromatic ring formation in a single enzymatic system. Several of
the mechanistic steps remain unclear and additional information
on the mechanism of such a multifunctional enzyme is of great
interest considering its potential as a drug target, being essential
for survival of several micro-organisms and plants [32,33], while
not being found in humans. Indeed, several pathogenic microor-
ganisms employ the DXP-independent pathway including Coryne-
bacterium diphteriae, Mycobacterium leprae and Plasmodium falciparum, the
latter being involved in the most severe form of malaria. Most
recently, the pathway has been shown to be essential for the
survival of Mycobacterium tuberculosis, a human pathogen the
infection from which claims close to 2 million lives annually
[34]. The high conservation of Pdx1 among organisms [3]
together with the structural characterization of PLP synthase
complexes from B. subtilis [17], T. maritima [18], G. thermophilus [19]
and S. cerevisiae [20] enabled us to select amino acid residues
potentially involved in catalysis of vitamin B6 biosynthesis. Several
studies have already resolved steps in the early stage of biosynthesis
of the vitamin [18,22,31,35,36]. Specifically, the reaction begins
with the binding of the pentose phosphate substrate (most likely in
its ring form). Opening of the furanose ring ensues and a covalent
adduct develops between the sugar and an active site lysine residue
in Pdx1 (K81 in B. subtilis) [18,22]. In the presence of the active
Michealis complex of Pdx2 and glutamine, this is followed by the
loss of inorganic phosphate and water, leading to a highly
conjugated arrangement that is chromophoric and is characterized
by an absorbance maximum at 315 nm [22]. However, the
remaining steps that occur upon G3P binding had not been
explored even though several plausible mechanistic versions had
been put forward [22,31,35,36]. Moreover, it had been noted that
although several residues at the P1 site in Pdx1 were confirmed to
be involved in catalysis, they did not suffice to map the entire
catalytic co-ordinate [17,22]. Here we contribute several observa-
tions to unraveling and confirming the remaining steps of PLP
biosynthesis. Firstly, we show that a conserved residue in the
flexible C-terminal region is not only necessary for formation of
the chromophoric intermediate in Pdx1 but is fundamental for the
positive co-operativity observed within the ornate PLP synthase
complex. As we have recently provided evidence that the C
terminus carries out its function on a neighboring subunit [21], we
hypothesize that this residue could function analogous to an
‘arginine finger’. Classically, an arginine finger is recognized as an
arginine residue located on an adjacent subunit that can
coordinate the phosphate group of a bound substrate, stabilize
the transition state during phosphate hydrolysis and/or act as a
trigger for conformational changes after hydrolysis [26]. Given
that we observed a strong defect in R5P binding with the R288A
Pdx1 mutant and no significant change in the release of inorganic
phosphate (Table S1 and Figure S2), the most likely role for this
residue is co-ordination of the phosphate group of R5P in the P1
site of an adjacent Pdx1 subunit. This hypothesis is corroborated
Figure 4. Steady state kinetics of BsAAT2. Asparate aminotrans-
ferase activity of BsAAT2 (4 mM) as isolated (#), BsAAT2 (4 mM) + Pdx1
wild type that had made PLP de novo (4 mM of PLP) (&), BsAAT2 +
apoPdx1 (.), BsAAT2 + Pdx1 with sodium borohydride reduced PLP
(n), BsAAT2 + Pdx2 (N). The decrease in absorbance at 340 nm upon
oxidation of NADH during the process of oxaloacetate oxidation to
malate facilitated by malate dehydrogenase is shown as a function of
the concentration of a-ketoglutarate. Assays were carried out in 30 mM
potassium phosphate buffer, pH 7.5, and at 25uC employing BsAAT2 as
isolated, malate dehydrogenase (0.25 mg/ml), NADH (0.2 mM), aspar-
tate (20 mM), Pdx1 wild type-PLP (4 mM of PLP), apoPdx1 wild type
(4 mM), Pdx1-reduced PLP (4 mM) and Pdx2 (4 mM). The concentration of
PLP bound to Pdx1 was estimated using an extinction coefficient of
5380 M
21.cm
21.
doi:10.1371/journal.pone.0016042.g004
Table 2. Summary of AAT2 kinetic constants
a.
AAT2 activity
KM a-
ketoglutarate kcat kcat/KM
(mM) (min
21)( m i n
21.mM
21)
AAT2 0.4060.05 2.960.1 7.3
AAT2 + Pdx1:PLP 0.3460.02 14.060.2 41.2
AAT2 + apoPdx1 0.2960.05 4.060.2 13.8
AAT2 + Pdx1:reduced
PLP
0.3060.05 4.460.2 14.7
AAT2 + Pdx2 0.3860.05 3.060.1 7.9
aAssays were performed at 25uC in 50 mM potassium phosphate containing
50 mM potassium chloride at pH 7.5.
doi:10.1371/journal.pone.0016042.t002
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that the R288A mutation completely abolishes the co-operativity
observed with R5P in Pdx1. Yet, we cannot rule out that this
arginine residue may be involved in the proton shuffling that
occurs on the way to forming the chromophoric intermediate.
However, arginine residues are generally protonated at physio-
logical pH and therefore considered poor candidates for the role of
general bases. Nevertheless, they have emerged as bases in several
enzymes [37]. In such a reaction, the arginine is activated by a
carboxylate group. In Pdx1, the catalytic role of D24 has been
confirmed [17], but the exact molecular nature of this role remains
unclear. In this context, it could act as an activator of R288
resulting in proton shuffling at C5 prior to phosphate elimination
as previously reported [35]. A tool for protein pKa prediction of
amino acids based on empirical relationships between protein pKa
shifts and structures called PROPKA [38] was used to give insights
into the nature of these residues. An average of the calculated
pKa’s of D24 from the Pdx1 dodecamer of B. subtilis (Protein Data
Bank code 2NV2) gave a value of 4.760.3.
Although, we show that the R288A mutant does not permit co-
operativity in Pdx1 alone, positive co-operativity is restored in the
presence of Pdx2 and glutamine (Figure 1G). Given the dependence
of co-operativity in this case on the preassembled PLP synthase
complex, it is worthnotingstructural features that arespecific to this
complex but are absent in Pdx1 alone. Among the most relevant is
the formation of helix, a29, above the R5P binding site in the PLP
synthase complex in the absence of substrate [17] and the
observation that in the presence of R5P, both a29 and a89 in the
PLP synthase complex move to tighten the Pdx1 P1 active site [21].
In the latter study, it was suggested that the movement of both a29
and a89, would additionally facilitate the movement of the Pdx1 C
terminus (not seen in the crystal structures) to a less exposed
environment, thus completing the closing of the active site albeit of
the adjacent protomer [21]. Thus, the positive co-operativity
observed for the Pdx1 R288A:R5P:Pdx2:glutamine assembled
complex can be said to be exclusively derived from the presence
of Pdx2 and glutamine. In other words, the R288 mutation
‘‘uncouples’’ the co-operativity imparted on the one hand by Pdx1
itself and on the other hand, that due to the Michaelis complex of
Pdx2 and glutamine upon binding R5P. This opens the way to
unravel the allosteric relay imparted by Pdx2 and glutamine on the
remote Pdx1 C terminus. Indeed, the complete absence of co-
operativity observed with the Pdx1 R288A mutant alone in the
presence of R5P suggests that the R288 residue is instrumental in
‘‘sensing’’ the presence of the substrate. If this arginine residue is to
additionally act in a catalytic capacity during the first steps of the
reaction, i.e. before formation of the chromophoric intermediate its
role could involve two steps, either: i) bestow rigidity to the C
terminus by stabilizing the binding of the pentose phosphate
substrate and thus permitting closure of the active site and/or ii)
perform proton abstraction after activation by D24 as postulated
above. Indeed, a role for an arginine and an aspartate residue in
both domain closure and catalysis has already been reported for
aspartate transcarbamylase from E. coli [39].
One of the most pertinent questions on the mechanism of PLP
synthase pertains to the functionality of the second phosphate-
bindingsite, P2, inPdx1. Site-directed mutagenesis of eitherH115A
or R138A within this site revealed a substantial effect on the
formationof PLP, demonstrating that theseresidues areessential for
catalysis. In particular, while the kinetic constants for chromophoric
intermediate formation with the Pdx1 H115A, R138A or the
corresponding double muteins are similar to those of the wild type
enzyme,thoseforPLP formationaresignificantly reduced.Notably,
there is a significant increase in the KM of G3P with the mutant
proteins in comparison to the wild type enzyme indicating impaired
binding of this substrate. As Pdx1 shares the canonical triose
phosphate isomerase fold (i.e. TIM barrel or (b/a)8 barrel) and the
latter enzyme catalyses the reversible interconversion of dihydroxy-
acetone phosphate (DHAP) and D-glyceraldehyde 3-phosphate, we
deemed a direct comparison with the active site of this enzyme
appropriate. We have previously shown that Pdx1 can utilize both
G3P and DHAP as substrates but has a strong preference for the
former [15]. Thus, although complete triose isomerization has not
been demonstrated for Pdx1, it could utilize H115 to donate a
proton to the triose sugar for the formation of an enediol
intermediate that is known to occur in the TIM reaction. Moreover,
making use of the PROPKA software [38] a pKa of 5.7560.2 was
calculated for H115 in Pdx1, which would support an acidic role for
this residue. However, no other residues analogous to the TIM
active site are present in the P2 site of Pdx1 with the exception of
K187 that projects into the site from a neighboring protomer on the
opposing hexameric ring (Figure 2A). Indeed, while the K187A
mutant shows a slight reduction of the catalytic activity for PLP
formation (Table 1B), it has a similar increase in KM for binding
G3P compared to the other Pdx1 P2 muteins suggesting that this
residue is more involved in binding the triose phosphate substrate
than in catalysis. However, we observed that the Pdx1 K187A
mutein is disrupted in the dodecamer:hexamer equilibrium
compared to wild-type under the same conditions and shows a
stronger tendency towards hexamer rather than dodecamer (Figure
S1C). As K187 is projecting into the Pdx1 P2 site from a protomer
on a neighboring hexamer and is therefore important in
maintaining the dodecameric state, this may be an alternative
explanation for the observed decrease in the affinity for G3P.
Nevertheless, the unequivocal demonstration that PLP is in a
Schiff’s base with K149 not only establishes a role for this residue
but moreover corroborates that the Pdx1 P2 site is necessary for
biosynthesis of the vitamin. While, mutagenesis of K149 showed
that it had a catalytic role to play during PLP biosynthesis [22], the
exact molecular role of this lysine residue has been a matter of
controversy in the literature. This residue was originally thought to
be the site of the pentose sugar substrate binding [16] but later both
mass spectrometric [22] and X-ray structural work [18] disproved
this idea, showing that K81 in P1 was the site of binding of R5P.
The presence of the second active site (P2) in Pdx1 involved in the
latter half of the reaction co-ordinate requires the transfer of a
reactionintermediatefrom theP1 totheP2site.While both sitesare
separated by 21 A ˚, the structural analyses have revealed a shallow
groove lined with charged residues that connects Pdx1 P1 and P2
[17]. Moreover, the catalytic impairment of the conserved residue,
E105, which is located between K81 and K149indicates that it may
play a role in this process. It remains to be established how and
when the relocationfromK81toK149occurs.Ithasbeenproposed
that K149 could be conceived to undergo a side chain rotation to
project into the Pdx1 P1 site [18,19] instead of P2 as is observed in
all of the structures determined so far. If this were to occur the NZ
atom of K149 would be able to approach C5 of the pentose sugar
substrate. However, with all of the data so far there is no obvious
way to explain what would trigger this ‘‘swinging arm’’ mechanism
[18,19] of K149 from Pdx1 P2 to P1 and back to P2. Thus, while it
is clear that P1 and P2 must co-operate and co-ordinate their
movements with each other to affect the production of the PLP
molecule the details of this dynamic ‘‘Tango’’ remain to be defined.
The final question we addressed was why the product remains
tightly bound to PLP synthase. Our data clearly demonstrate that
an enzyme dependent on the PLP product as a cofactor is capable
of removing it from Pdx1 and utilizing it for catalytic activity. This
represents an additional level of regulation for the PLP synthase
Insight into the Mechanism of PLP Synthase
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the reactive aldehyde product is not released into the cellular
milieu, where it could cause damage by reacting non-specifically
with exposed lysine residues in proteins not dependent on PLP as a
cofactor or complexing with free amino acids. As a corollary this
implies that PLP synthase is primed for donating the product of its
reaction and only does so when required and furthermore suggests
that the ornate dodecameric architecture could serve as a storage
form of the vitamin. Interestingly, pyridoxine oxidase, an enzyme
of the salvage pathway that is present in all organisms, also retains
the product PLP in a tight binding complex [40]. Therefore, we
propose that the mechanism of PLP transfer can be generalized to
all PLP dependent enzymes and opens an area for future
investigation. Notably, enzymes catalyzing the formation of any
of the other vitamers of B6, e.g. pyridoxol and pyridoxamine and
their phosphorylated derivatives do not bind the products of their
reactions tightly [10,41]. Given the importance of this vitamin in
nature, the work described here provides insight into yet another
aspect of the fascinating control the cell imposes on itself in order
to curtail possible points of damage and maintain functionality.
*While this manuscript was undergoing completion, we learned that the X-
ray structure of PLP synthase from S. cerevisiae with PLP and G3P bound
was accepted for publication [42]. This article apparently confirms the
presence of PLP in the P2 site, although they did not comment on if it was in a
Schiff’s base with K149. Interestingly, G3P was reported to bind in a third
active site, based on co-crystallization of the apo-form with 10 mM
dihydroxyacetone phosphate. However, neither the structures nor any kinetic
data of implicated residues were available yet to judge this conclusion.
Materials and Methods
Protein expression and purification
The constructs pETBsPdx1 and pETBsPdx2-His6 described by
Raschle et al. (2005), in addition to pETBsPdx1-His6 and Pdx2-
His6 H170N described by Strohmeier et al. (2006) were used in
this study. The construct pETBsAAT2 was generated by
amplification of the B. subtilis AAT2 gene with primers CTAGC-
TAGCATGGAAATAACACCGTCCGATGTC and CCGC-
TCGAGGCGGGATGTTTCTT-GTAATGACC that incorpo-
rate an NheI and XhoI restriction site at the 59 and 39 ends,
respectively, for cloning into of pET21a (EMD Biosciences) such
that when expressed a hexahistidine tag would be included at the
C terminus. Protein expression and purification, for both the
native and hexahistidine tagged proteins, were carried out as
described by Raschle et al. (2005) and monitored by SDS-PAGE
on either 12.5 or 15% polyacrylamide gels and staining with
Coomassie Blue. Protein concentration was determined by the
method of Bradford using bovine serum albumin as a standard
[43].
Site directed mutagenesis
Site directed mutagenesis of Pdx1 for single and double mutants
was carried out using the QuikChangeH XL Site Directed
Mutagenesis Kit (Stratagene). The oligonucleotides used for
mutagenesis are listed in Table S2.
Enzyme assays
Distinct enzyme activities of PLP synthase can be separately
measured as previously described [15,22], namely the rate of
glutamine hydrolysis by Pdx2, the formation of the end product
PLP, the formation of the chromophoric reaction intermediate
and the release of inorganic phosphate. All of these enzyme
activities are detectable by UV-visible spectrophotometry. Gluta-
minase activity of Pdx2 was monitored by a coupled enzyme assay
as described by Raschle et al. (2005). PLP formation was
monitored by the change in absorbance at 414 nm in the presence
of R5P, G3P, Pdx1 and glutamine, as described by Raschle et al.
(2005, 2007). Formation of the chromophoric reaction interme-
diate was determined by the increase in absorbance at 315 nm in
the presence of Pdx1, Pdx2, R5P, and glutamine [15]. Measure-
ment of the release of inorganic phosphate was monitored by a
coupled enzyme assay (EnzCheckH phosphate assay kit, Molecular
Probes) as described by Raschle et al. (2007). AAT2 activity was
determined via a coupled reaction with malate dehydrogenase as
previously reported [44]. In this assay, the enzymatic conversion of
L-aspartate and a-ketoglutarate to L-glutamate and oxaloacetate
by AAT2 was measured. The decrease in absorbance at 340 nm
upon oxidation of NADH during the process of oxaloacetate
oxidation to malate facilitated by malate dehydrogenase is shown
as a function of the concentration of a-ketoglutarate. Assays were
carried out in 30 mM potassium phosphate buffer, pH 7.5, and at
25uC employing BsAAT2 (4 mM), malate dehydrogenase
(0.25 mg/ml), NADH (0.2 mM), aspartate (20 mM), Pdx1 that
had made PLP de novo (4 mM of PLP), apoPdx1 (4 mM), Pdx1-
reduced de novo synthesized PLP (4 mM) and Pdx2 ( mM). The
concentration of PLP bound to Pdx1 was estimated using an
extinction coefficient of 5380 M
21.cm
21.
Equilibrium binding monitored by intrinsic protein
fluorescence
The steady-state fluorescence measurements were conducted on
a QuantaMaster 4 spectrofluorometer (Photon Technology
International, Seefeld, Germany) as described previously [21].
The steady state kinetics for ribose 5-phosphate binding displayed
sigmoidal behavior and were thus determined by nonlinear curve
fitting to the Hill equation:
FR 5P ½  ðÞ ~F0z
DF: R5P ½ 
h
Kh
0:5z R5P ½ 
h
Where F([R5P]) represents the fluorescence signal at a given
R5P concentration, F0 is the minimal fluorescence signal, DF is the
maximal change in fluorescence intensity, K0.5 is the R5P
concentration at half-maximal fluorescence signal, and h is the
Hill coefficient.
Size exclusion chromatography and multi-angle light
scattering (MALS) experiments
Native wild type or R288A Pdx1 as well as the hexahistidine
tagged Pdx1 K187A (100 ml at 1 mg/ml) were first separated by
size exclusion chromatography on a Superdex 200 10/300 GL
column (GE Healthcare). The elution buffer was 50 mM
potassium phosphate, pH 7.5, containing 50 mM potassium
chloride and 0.01% sodium azide. A miniDAWN TREOS light
scattering instrument (Wyatt Technologies, USA) was connected
immediately downstream of the separation media for light
scattering analysis. The data were analyzed using the software
ASTRA (Wyatt Technologies, USA). An absorption coefficient of
368.0 (ml.g
21.cm
21) for BsPdx1 wild type, 369.0 (ml.g
21.cm
21)
for Pdx1 R288A and 353.5 (ml.g
21.cm
21) for the Pdx1 K187A
enzyme was used for the calculation of the weight average
molecular mass (Mw).
Identification of the peptide containing PLP
Isolated Pdx1 wild type was incubated with 1 mM DL-G3P,
1 mM R5P and 10 mM ammonium sulfate for 3 h at room
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enzyme was performed by treatment with 4 mM sodium
borohydride at 4uC. The resulting enzyme (1–1.2mg) was treated
with 10 mg of trypsin (Sequencing Grade Modified Trypsin,
Promega) in 50 mM Tris-Cl pH 7.5 at 37uC overnight. Digestion
was terminated by the addition of formic acid to a final
concentration of 2.7%, and the sample was centrifuged at
159000 g for 30 min. The supernatant was applied to a C18
reversed-phase column XDB (1.8 mm, 4.6650 mm, Agilent)
equipped with a UV detector to monitor absorption at 215 nm
and a fluorescence detector to monitor the reduced pyridoxal 59-
phosphate probe (excitation at 320 nm and emission at 390 nm).
A gradient of 0–60% acetonitrile/1% trifluoroacetic acid (v/v) at
1 ml.min
21 was established over 45 min, held for 5 min, raised to
80% acetonitrile/1% trifluoroacetic acid (v/v) over 10 min, and
then returned to the starting conditions over 15 min. Fractions of
interest were analyzed by MALDI-TOF/TOF mass spectrometry
(Bruker Ultraflex II).
Supporting Information
Figure S1 Size exclusion chromatography coupled to
static light scattering analysis of Pdx1 wild type, R288A
and K187A. Prior to multi-angle light scattering (MALS)
measurements, size exclusion chromatography (SEC) was per-
formed using a Superdex 200 10/300 column in 50 mM
potassium phosphate buffer, pH 7.5, containing 50 mM potassi-
um chloride using 1 mg/ml of enzyme. The combination of SEC
and MALS reveal a predominant peak corresponding to the
dodecameric form of Pdx1 (A) wild type or (B) Pdx1 R288A
whereas (C) Pdx1K187A exhibits a dodecamer:hexamer equilib-
rium. The weight average molecular mass Mw mass (black line) and
the Rayleigh ratio (gray line) were plotted in an elution volume
dependent manner.
(TIF)
Figure S2 Steady state kinetics for the release of
inorganic phosphate from Pdx1 wild type (#), R288A
(N) or R288K (.). The rate of inorganic phosphate release
was monitored employing a coupled enzymatic assay. The
reaction was carried out in 50 mM Tris-Cl pH 7.5, containing
20 mM magnesium chloride, employing Pdx1 wild type or
muteins (20 mM), Pdx2 (20 mM), glutamine (10 mM), 2-amino-6-
mercapto-7-methyl-purine (0.2 mM) and purine nucleoside phos-
phorylase (1.5 U) as a function of the concentration of R5P.
(TIF)
Table S1
(DOC)
Table S2
(DOC)
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